|
|
||||||||
Ann Thorac Surg 2001;71:S282-S284
© 2001 The Society of Thoracic Surgeons
a Division of Cardiovascular Surgery, Department of Surgery, University of British Columbia, British Columbia, Vancouver, Canada
Address reprint requests to Dr Jamieson, St. Pauls Hospital, 331-332 Burrard Building, 1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada
e-mail: wrej{at}interchange.ubc.ca
Presented at the VIII International Symposium on Cardiac Bioprostheses, Cancun, Mexico, Nov 35, 2000.
Background. The hemodynamic performance of aortic replacement prostheses is of extreme importance. There is renewed interest in hemodynamics because of the influence of prosthesispatient mismatch on left ventricular mass regression and the potential influence on survival.
Methods. The hemodynamic performance of the second-generation Carpentier-Edwards supraannular porcine and pericardial (Perimount) bioprostheses and the third-generation Medtronic Mosaic porcine bioprosthesis were compared for mean gradient and effective orifice area index. The effective orifice area index of at least 0.85 cm2/M2 was considered as lack of prosthesispatient mismatch. The study group included included 53 patients with Carpentier-Edwards supraannular porcine, 48 with pericardial, and 98 with Medtronic Mosaic porcine bioprostheses.
Results. The mean gradients were not different between the prostheses by prosthesis size. The Medtronic Mosaic was not provided in size 19. The mean gradients for the prostheses, except in the very large sizes, were all double-digit values. The effective orifice area index was not different between the prostheses but there was a trend toward prosthesis-patient mismatch in smaller size prostheses.
Conclusions. There was no apparent hemodynamic advantage between porcine and pericardial bioprostheses in the aortic position.
This article has been cited by other articles:
![]() |
M. J. Dalmau, J. Maria Gonzalez-Santos, J. Lopez-Rodriguez, M. Bueno, A. Arribas, and F. Nieto One year hemodynamic performance of the Perimount Magna pericardial xenograft and the Medtronic Mosaic bioprosthesis in the aortic position: a prospective randomized study Interactive CardioVascular and Thoracic Surgery, June 1, 2007; 6(3): 345 - 349. [Abstract] [Full Text] [PDF] |
||||
![]() |
F.-C. Riess, R. Bader, E. Cramer, L. Hansen, B. Kleijnen, G. Wahl, J. Wallrath, S. Winkel, and N. Bleese Hemodynamic Performance of the Medtronic Mosaic Porcine Bioprosthesis Up to Ten Years Ann. Thorac. Surg., April 1, 2007; 83(4): 1310 - 1318. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.R. E. Jamieson, S. D. Moffatt-Bruce, P. Skarsgard, M. A. Hadi, J. Ye, G. J. Fradet, J. G. Abel, M. T. Janusz, A. Cheung, and E. Germann Early Antithrombotic Therapy for Aortic Valve Bioprostheses: Is There an Indication for Routine Use? Ann. Thorac. Surg., February 1, 2007; 83(2): 549 - 557. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al. ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Developed in Collaboration With the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons J. Am. Coll. Cardiol., August 1, 2006; 48(3): e1 - e148. [Full Text] [PDF] |
||||
![]() |
A. P. Kappetein, J. J.M. Takkenberg, J. P.A. Puvimanasinghe, W.R. E. Jamieson, M. Eijkemans, and Ad.J.J.C. Bogers Does the type of biological valve affect patient outcome? Interactive CardioVascular and Thoracic Surgery, August 1, 2006; 5(4): 398 - 402. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. E. Jamieson, E. Germann, M. R Aupart, P. H Neville, M. A Marchand, and G. J Fradet 15-Year Comparison of Supra-Annular Porcine and PERIMOUNT Aortic Bioprostheses Asian Cardiovasc Thorac Ann, June 1, 2006; 14(3): 200 - 205. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Totaro, N. Degno, A. Zaidi, A. Youhana, and V. Argano Carpentier-Edwards PERIMOUNT Magna bioprosthesis: A stented valve with stentless performance? J. Thorac. Cardiovasc. Surg., December 1, 2005; 130(6): 1668 - 1674. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Walther, S. Lehmann, V. Falk, S. Metz, N. Doll, A. Rastan, M. Viehweg, M. Richter, J. Gummert, and F. W. Mohr Prospectively Randomized Evaluation of Stented Xenograft Hemodynamic Function in the Aortic Position Circulation, September 14, 2004; 110(11_suppl_1): II-74 - II-78. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Gao, Y. Wu, G. L. Grunkemeier, A. P. Furnary, and A. Starr Durability of pericardial versus porcine aortic valves J. Am. Coll. Cardiol., July 21, 2004; 44(2): 384 - 388. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Bottio, G. Rizzoli, G. Thiene, G. Nesseris, D. Casarotto, and G. Gerosa Hemodynamic and clinical outcomes with the Biocor valve in the aortic position: An 8-year experience J. Thorac. Cardiovasc. Surg., June 1, 2004; 127(6): 1616 - 1623. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Seitelberger, J. Bialy, R. Gottardi, G. Seebacher, R. Moidl, M. Mittelbock, P. Simon, and E. Wolner Relation between size of prosthesis and valve gradient: comparison of two aortic bioprosthesis Eur. J. Cardiothorac. Surg., March 1, 2004; 25(3): 358 - 363. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |